documents: FDA-2026-N-0707-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-0707-0001 | FDA | FDA-2026-N-0707 | GlaxoSmithKline; Withdrawal of Approval of a New Drug Application for Wellcovorin (Leucovorin Calcium) Tablets, EQ 5 mg Base and EQ 25 mg Base | Notice | Withdrawal | 2026-04-10T04:00:00Z | 2026 | 4 | 2026-04-10T04:00:00Z | 2026-04-10T17:40:29Z | 2026-06911 | 0 | 0 | 09000064b926837d |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref